This data is in accordance with the study developed by Hollstein and colleagues, who previously described the absence of mutations in KRAS in ESCC of patients from Normandy (France) and Uruguay[39], while no study had investigated BRAF mutations in ESCC so far. Here, KRAS is linked to esophageal squamous cell carcinoma.